<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-F6IODP3A</identifier><date>2020</date><creator>Gobec, Stanislav</creator><creator>Kikelj, Danijel</creator><creator>Obreza, Aleš</creator><relation>documents/doc/F/URN_NBN_SI_doc-F6IODP3A_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-F6IODP3A_001.txt</relation><format format_type="issue">1</format><format format_type="volume">71</format><format format_type="type">article</format><format format_type="extent">str. 55-61</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4898417</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-F6IODP3A</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Bakterijska rezistenca</subject><subject language_type_id="slv">Farmacevtska kemija</subject><subject language_type_id="slv">protimikrobne učinkovine</subject><title>Ali lahko z novimi protimikrobnimi učinkovinami zmagamo v boju z bakterijami?</title><title>Can we win the fight with bacteria using new antimicrobial compounds?</title></Record>